NEWSROOM
News & Stories
Newsroom
Press Releases
Agendia Reports More Than 20,000 MammaPrint Breast Cancer Recurrence Results
IRVINE, CA, May 2, 2013 โ Agendia, a world leader in molecular cancer diagnostics, today announced that it has reported more than 20,000 MammaPrint breast cancer results, including approximately 6,000 in 2012 alone. ย The MammaPrint Read More
Study shows half of early-stage breast cancer patients may be able to avoid chemotherapy
Agendia Announces Launch of ColoPrint for Colon Cancer Prognosis and Prediction
MammaPrint breast cancer test IDโs women who can avoid chemotherapy
KARE, Minneapolis-St.Paul-2013 This TV report tells how you can โknow your breast cancerโ better through this genomic, personalized medicine test, which is part of the Symphony suite of breast cancer tests.